Results 61 to 70 of about 122,466 (202)

Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts

open access: yesMolecules, 2014
BPC 157, a pentadecapeptide derived from human gastric juice, has been demonstrated to promote the healing of different tissues, including skin, muscle, bone, ligament and tendon in many animal studies.
Chung-Hsun Chang   +3 more
doaj   +3 more sources

BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185 [PDF]

open access: yesPharmaceuticals
The healing issue is a central, not completely understood, problem in pharmacology, approached by many concepts. One of the most well-known is Robert’s and Szabo’s concept of cytoprotection, which holds innate cell (epithelial (Robert), endothelial ...
Predrag Sikiric   +15 more
doaj   +2 more sources

Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. [PDF]

open access: yesCurr Rev Musculoskelet Med
McGuire FP   +4 more
europepmc   +2 more sources

PENTADECAPEPTIDE BPC 157 RESOLVES TOURNIQUET INDUCED ISCHEMIAREPERFUSION INJURY

open access: yesLiječnički vjesnik, 2023
This study aimed to investigate tourniquet-induced compartment syndrome of the limb, consequential development of multiple organ dysfunction syndrome, and its counteraction with pentadecapeptide BPC 157 therapy.
Katarina Oroz   +3 more
doaj   +3 more sources

Antinociceptive Effect of BPC-157 in the Formalin-induced Pain Model [PDF]

open access: yesKosin Medical Journal, 2021
Objectives Body protective compound-157 (BPC-157) is a stable gastric pentadecapeptide that has been effective in trials aiming to increase wound healing capabilities and decrease inflammatory cell influx, including studies on the healing of muscles and ...
Sang Yoong Park   +6 more
doaj   +1 more source

Novelties regarding pentadecapeptide BPC-157

open access: yesBiomedicine and surgery, 2021
Stable gastric pentadecapeptide BPC-157 is a novel anti-ulcer peptide, used in trials for the treatment of ulcerative colitis and now multiple sclerosis. That fifteen amino acid molecule is likely mediator of Robert s stomach cytoprotection/adaptive cytoprotection and organoprotection, as well as a novel mediator of Selye s stress coping response ...
Amić, Fedor   +2 more
openaire   +2 more sources

Stable gastric pentadecapeptide BPC 157

open access: yesJournal of physiology and pharmacology, 2009
Considering peptidergic drugs, many cytokines, enzymes, clotting factors registered for the use as therapeutic agents in specific conditions, they are mainly given by injection, only occasionally by other routes. Also, to ascertain delivery and activity, they use different carriers, peptide+carrier complex may provide significant methodology/activity ...
Sikirić, Predrag   +3 more
  +7 more sources

Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine. [PDF]

open access: yesPLoS ONE, 2015
BPC 157 is a stable gastric pentadecapeptide recently implicated with a role in hemostasis. While NO is largely implicated in hemostatic mechanisms, in tail-amputation-models under heparin- and warfarin-administration, both the NO-synthase (NOS)-blocker,
Mirjana Stupnisek   +11 more
doaj   +1 more source

Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy

open access: yesCurrent Pharmaceutical Design, 2020
This review is focused on the healing of fistulas and stable gastric pentadecapeptide BPC 157. Assuming that the healing of the various wounds is essential also for the gastrointestinal fistulas healing, the healing effect on fistulas in rats, consistently noted with the stable gastric pentadecapeptide BPC 157, may raise several interesting ...
Predrag Sikiric   +17 more
  +7 more sources

In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro

open access: yesEmergency Medicine International, 2020
Recently, the pentadecapeptide BPC 157-induced counteraction of bupivacaine cardiotoxicity has been reported. Medication includes (i) lidocaine-induced local anesthesia via intraplantar application and axillary and spinal (L4-L5) intrathecal block, (ii ...
Marin Lozic   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy